Product Code: ETC13313769 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Brucellosis Vaccine Market was valued at USD 0.62 Billion in 2024 and is expected to reach USD 0.91 Billion by 2031, growing at a compound annual growth rate of 5.96% during the forecast period (2025-2031).
The Global Brucellosis Vaccine Market is witnessing steady growth due to the rising prevalence of brucellosis, particularly in livestock animals. The market is driven by the increasing adoption of vaccination programs in various regions to control the spread of the disease among animals and minimize the risk of transmission to humans. Key players in the market are focusing on developing advanced brucellosis vaccines with improved efficacy and safety profiles. Additionally, government initiatives aimed at promoting animal health and welfare are further contributing to market growth. North America and Europe are significant markets for brucellosis vaccines, with Asia Pacific showing promising growth potential. Overall, the market is projected to continue expanding as awareness about the importance of brucellosis prevention increases among livestock owners and government agencies.
The Global Brucellosis Vaccine Market is witnessing a growing demand due to increasing awareness about zoonotic diseases and the importance of livestock health. Government initiatives to control brucellosis outbreaks and the rising adoption of vaccination programs in livestock farms are driving market growth. Technological advancements in vaccine development, such as the use of recombinant DNA technology and novel adjuvants, are further propelling the market. Additionally, the expanding livestock industry in developing countries and the rising focus on food safety are creating opportunities for market expansion. Moreover, collaborations between research institutions and pharmaceutical companies for the development of efficient vaccines are expected to fuel market growth in the coming years.
The Global Brucellosis Vaccine Market faces several challenges, including limited awareness about the disease in some regions, leading to low demand for vaccines. Additionally, the high cost of vaccine development and manufacturing, coupled with regulatory hurdles in some countries, can hinder market growth. Furthermore, the lack of standardized diagnostic methods for brucellosis can result in misdiagnosis and underreporting of cases, impacting the overall market potential. Inadequate infrastructure and resources in certain regions also pose challenges in vaccine distribution and access to preventive healthcare services. Overall, addressing these challenges requires collaborative efforts among stakeholders, including governments, healthcare providers, and pharmaceutical companies, to improve awareness, affordability, and accessibility of brucellosis vaccines globally.
The global Brucellosis vaccine market is primarily driven by the increasing prevalence of Brucellosis infection in livestock animals, leading to economic losses in the agricultural sector. Governments and regulatory bodies across several countries are emphasizing the implementation of vaccination programs to control and eradicate Brucellosis, further boosting the demand for vaccines. Additionally, growing awareness about zoonotic diseases and the importance of preventing transmission from animals to humans is driving the adoption of Brucellosis vaccines in regions where the disease is endemic. Technological advancements in vaccine development, such as the introduction of novel formulations and delivery methods, are also contributing to market growth. Furthermore, the rising demand for sustainable farming practices and food safety concerns are expected to fuel the market for Brucellosis vaccines in the coming years.
Government policies related to the Global Brucellosis Vaccine Market vary across countries but generally focus on the regulation and promotion of effective vaccination strategies to control the spread of the disease in both animals and humans. Many governments prioritize the development and distribution of safe and affordable brucellosis vaccines, often supporting research initiatives and collaborations with international organizations. Additionally, some countries have implemented mandatory vaccination programs for livestock to prevent the transmission of brucellosis to humans through contaminated dairy products. Government agencies also work to ensure the quality and efficacy of brucellosis vaccines through regulatory approvals and monitoring processes to safeguard public health and support the growth of the global brucellosis vaccine market.
The global brucellosis vaccine market is expected to witness significant growth in the coming years, driven by increasing awareness about brucellosis prevention and the rise in livestock farming activities worldwide. The market is likely to be fueled by government initiatives promoting vaccination programs, especially in regions with a high prevalence of brucellosis. Technological advancements in vaccine development, such as the introduction of novel vaccine formulations and delivery systems, are anticipated to further boost market growth. Additionally, the growing demand for safe and effective vaccines to protect both animals and humans from brucellosis is projected to drive market expansion. Overall, the global brucellosis vaccine market shows promising opportunities for market players to capitalize on the increasing need for preventive healthcare solutions in the livestock industry.
The Global Brucellosis Vaccine Market shows a varied landscape across different regions. In Asia, the market is primarily driven by the high prevalence of brucellosis in countries like China and India, leading to increased demand for vaccines. North America and Europe have well-established veterinary healthcare systems, resulting in a higher adoption rate of brucellosis vaccines among livestock. The Middle East and Africa region experiences a significant burden of brucellosis in both animals and humans, driving the market for vaccines. Latin America faces challenges in brucellosis control due to inadequate resources, but efforts are being made to improve vaccination strategies. Overall, the market is witnessing growth opportunities in all regions as awareness about brucellosis prevention and control continues to rise.
Global Brucellosis Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Brucellosis Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Brucellosis Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Brucellosis Vaccine Market - Industry Life Cycle |
3.4 Global Brucellosis Vaccine Market - Porter's Five Forces |
3.5 Global Brucellosis Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Brucellosis Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Global Brucellosis Vaccine Market Revenues & Volume Share, By Strain Used, 2021 & 2031F |
3.8 Global Brucellosis Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Brucellosis Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Brucellosis Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Brucellosis Vaccine Market Trends |
6 Global Brucellosis Vaccine Market, 2021 - 2031 |
6.1 Global Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Brucellosis Vaccine Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.3 Global Brucellosis Vaccine Market, Revenues & Volume, By Inactivated Vaccine, 2021 - 2031 |
6.1.4 Global Brucellosis Vaccine Market, Revenues & Volume, By Subunit Vaccine, 2021 - 2031 |
6.1.5 Global Brucellosis Vaccine Market, Revenues & Volume, By DNA Vaccine, 2021 - 2031 |
6.2 Global Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Brucellosis Vaccine Market, Revenues & Volume, By Brucella abortus RB51, 2021 - 2031 |
6.2.3 Global Brucellosis Vaccine Market, Revenues & Volume, By Killed Brucella Strains, 2021 - 2031 |
6.2.4 Global Brucellosis Vaccine Market, Revenues & Volume, By Antigen-Based Formulation, 2021 - 2031 |
6.2.5 Global Brucellosis Vaccine Market, Revenues & Volume, By Genetic Engineering, 2021 - 2031 |
6.3 Global Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Brucellosis Vaccine Market, Revenues & Volume, By Livestock Immunization, 2021 - 2031 |
6.3.3 Global Brucellosis Vaccine Market, Revenues & Volume, By Human Brucellosis Prevention, 2021 - 2031 |
6.3.4 Global Brucellosis Vaccine Market, Revenues & Volume, By Research & Development, 2021 - 2031 |
6.3.5 Global Brucellosis Vaccine Market, Revenues & Volume, By High-Risk Occupations, 2021 - 2031 |
6.4 Global Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Brucellosis Vaccine Market, Revenues & Volume, By Veterinary Sector, 2021 - 2031 |
6.4.3 Global Brucellosis Vaccine Market, Revenues & Volume, By Public Health Programs, 2021 - 2031 |
6.4.4 Global Brucellosis Vaccine Market, Revenues & Volume, By Biopharmaceutical Industry, 2021 - 2031 |
6.4.5 Global Brucellosis Vaccine Market, Revenues & Volume, By Agricultural Workers, 2021 - 2031 |
7 North America Brucellosis Vaccine Market, Overview & Analysis |
7.1 North America Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.4 North America Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
7.5 North America Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Brucellosis Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
8.4 Latin America (LATAM) Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
8.5 Latin America (LATAM) Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Brucellosis Vaccine Market, Overview & Analysis |
9.1 Asia Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
9.4 Asia Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
9.5 Asia Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Brucellosis Vaccine Market, Overview & Analysis |
10.1 Africa Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
10.4 Africa Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
10.5 Africa Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Brucellosis Vaccine Market, Overview & Analysis |
11.1 Europe Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
11.4 Europe Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
11.5 Europe Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Brucellosis Vaccine Market, Overview & Analysis |
12.1 Middle East Brucellosis Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Brucellosis Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Brucellosis Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Brucellosis Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
12.4 Middle East Brucellosis Vaccine Market, Revenues & Volume, By Strain Used, 2021 - 2031 |
12.5 Middle East Brucellosis Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Brucellosis Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Brucellosis Vaccine Market Key Performance Indicators |
14 Global Brucellosis Vaccine Market - Export/Import By Countries Assessment |
15 Global Brucellosis Vaccine Market - Opportunity Assessment |
15.1 Global Brucellosis Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Brucellosis Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
15.3 Global Brucellosis Vaccine Market Opportunity Assessment, By Strain Used, 2021 & 2031F |
15.4 Global Brucellosis Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Brucellosis Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Brucellosis Vaccine Market - Competitive Landscape |
16.1 Global Brucellosis Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Brucellosis Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |